COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #32
Source   PDF   Share   Tweet
See all 143 studies
5/11
Inconc.
Late treatment study
Shabrawishi et al., medRxix, doi:10.1101/2020.05.08.20095679 (Preprint)
Negative nasopharyngeal SARS-CoV-2 PCR conversion in response to different therapeutic interventions
Retrospective 93 hospitalized patients in Saudi Arabia showing a non-statistically significant 15% reduction in PCR positive results at day 5, RR 0.85, p = 0.65. The treatment group had significantly more severe illness and significantly more male patients.
no virological cure, ↓14.7%, p=0.66, risk of no virological cure at day 5
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit